Novartis AG (NVS)
103.85
+0.76
(+0.74%)
USD |
NYSE |
Nov 21, 16:00
103.80
-0.05
(-0.05%)
After-Hours: 20:00
Novartis 1 Year Total Returns (Daily): 11.82% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 11.82% |
November 20, 2024 | 12.32% |
November 19, 2024 | 12.92% |
November 18, 2024 | 12.67% |
November 15, 2024 | 14.03% |
November 14, 2024 | 13.06% |
November 13, 2024 | 14.56% |
November 12, 2024 | 16.41% |
November 11, 2024 | 17.24% |
November 08, 2024 | 17.05% |
November 07, 2024 | 18.45% |
November 06, 2024 | 18.62% |
November 05, 2024 | 22.37% |
November 04, 2024 | 23.65% |
November 01, 2024 | 20.39% |
October 31, 2024 | 20.22% |
October 30, 2024 | 21.66% |
October 29, 2024 | 24.32% |
October 28, 2024 | 30.05% |
October 25, 2024 | 23.75% |
October 24, 2024 | 23.70% |
October 23, 2024 | 25.02% |
October 22, 2024 | 25.31% |
October 21, 2024 | 26.85% |
October 18, 2024 | 26.54% |
Date | Value |
---|---|
October 17, 2024 | 25.31% |
October 16, 2024 | 24.92% |
October 15, 2024 | 24.04% |
October 14, 2024 | 24.12% |
October 11, 2024 | 21.33% |
October 10, 2024 | 21.00% |
October 09, 2024 | 22.97% |
October 08, 2024 | 21.55% |
October 07, 2024 | 21.64% |
October 04, 2024 | 22.98% |
October 03, 2024 | 25.45% |
October 02, 2024 | 23.64% |
October 01, 2024 | 23.34% |
September 30, 2024 | 23.84% |
September 27, 2024 | 26.46% |
September 26, 2024 | 25.02% |
September 25, 2024 | 25.42% |
September 24, 2024 | 26.24% |
September 23, 2024 | 26.19% |
September 20, 2024 | 22.76% |
September 19, 2024 | 23.60% |
September 18, 2024 | 24.61% |
September 17, 2024 | 23.64% |
September 16, 2024 | 24.98% |
September 13, 2024 | 25.87% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-10.67%
Minimum
Jan 25 2022
44.88%
Maximum
Oct 11 2023
10.87%
Average
7.96%
Median
1 Year Total Returns (Daily) Benchmarks
AstraZeneca PLC | 2.13% |
Johnson & Johnson | 5.33% |
Eli Lilly and Co | 27.37% |
Novo Nordisk AS | 0.96% |
Monte Rosa Therapeutics Inc | 180.2% |